Lavasanifar A - Search Results

1

P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.

Binkhathlan Z, Lavasanifar A. Binkhathlan Z, et al. Among authors: lavasanifar a. Curr Cancer Drug Targets. 2013 Mar;13(3):326-46. doi: 10.2174/15680096113139990076. Curr Cancer Drug Targets. 2013. PMID: 23369096 Review.

2

Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery.

Lavasanifar A, Samuel J, Kwon GS. Lavasanifar A, et al. Adv Drug Deliv Rev. 2002 Feb 21;54(2):169-90. doi: 10.1016/s0169-409x(02)00015-7. Adv Drug Deliv Rev. 2002. PMID: 11897144 Review.

3

Block copolymer micelles for the encapsulation and delivery of amphotericin B.

Lavasanifar A, Samuel J, Sattari S, Kwon GS. Lavasanifar A, et al. Pharm Res. 2002 Apr;19(4):418-22. doi: 10.1023/a:1015127225021. Pharm Res. 2002. PMID: 12033373

4

Polymeric micelles for drug delivery.

Aliabadi HM, Lavasanifar A. Aliabadi HM, et al. Among authors: lavasanifar a. Expert Opin Drug Deliv. 2006 Jan;3(1):139-62. doi: 10.1517/17425247.3.1.139. Expert Opin Drug Deliv. 2006. PMID: 16370946 Review.

5

Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells.

Xiong XB, Mahmud A, Uludağ H, Lavasanifar A. Xiong XB, et al. Among authors: lavasanifar a. Biomacromolecules. 2007 Mar;8(3):874-84. doi: 10.1021/bm060967g. Epub 2007 Feb 22. Biomacromolecules. 2007. PMID: 17315946

6

Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors.

Molavi O, Ma Z, Mahmud A, Alshamsan A, Samuel J, Lai R, Kwon GS, Lavasanifar A. Molavi O, et al. Among authors: lavasanifar a. Int J Pharm. 2008 Jan 22;347(1-2):118-27. doi: 10.1016/j.ijpharm.2007.06.032. Epub 2007 Jun 26. Int J Pharm. 2008. PMID: 17681440 Free PMC article.

7

Polymeric micellar delivery reduces kidney distribution and nephrotoxic effects of Cyclosporine A after multiple dosing.

Aliabadi HM, Elhasi S, Brocks DR, Lavasanifar A. Aliabadi HM, et al. Among authors: lavasanifar a. J Pharm Sci. 2008 May;97(5):1916-26. doi: 10.1002/jps.21036. J Pharm Sci. 2008. PMID: 17786948

8

Polymeric micelles for drug targeting.

Mahmud A, Xiong XB, Aliabadi HM, Lavasanifar A. Mahmud A, et al. Among authors: lavasanifar a. J Drug Target. 2007 Nov;15(9):553-84. doi: 10.1080/10611860701538586. J Drug Target. 2007. PMID: 17968711 Review.

9

Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol.

Ma Z, Molavi O, Haddadi A, Lai R, Gossage RA, Lavasanifar A. Ma Z, et al. Among authors: lavasanifar a. Cancer Chemother Pharmacol. 2008 Dec;63(1):27-35. doi: 10.1007/s00280-008-0704-z. Epub 2008 Feb 20. Cancer Chemother Pharmacol. 2008. PMID: 18286288

10

Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells.

Xiong XB, Mahmud A, Uludağ H, Lavasanifar A. Xiong XB, et al. Among authors: lavasanifar a. Pharm Res. 2008 Nov;25(11):2555-66. doi: 10.1007/s11095-008-9673-5. Epub 2008 Jul 18. Pharm Res. 2008. PMID: 18636321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results